| ［1］ |
中华医学会皮肤性病学分会荨麻疹研究中心. 中国荨麻疹诊疗指南（2018版）［J］. 中华皮肤科杂志, 2019,52（1）:1⁃5. doi: 10.3760/cma.j.issn.0412⁃4030.2019.01.001.
|
| ［2］ |
Maurer M, Fluhr JW, Khan DA. How to approach chronic inducible urticaria［J］. J Allergy Clin Immunol Pract, 2018,6（4）:1119⁃1130. doi: 10.1016/j.jaip.2018.03.007.
|
| ［3］ |
Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria［J］. Allergy, 2022,77（3）:734⁃766. doi: 10.1111/all.15090.
|
| ［4］ |
Schaefer P. Acute and chronic urticaria: evaluation and treatment［J］. Am Fam Physician, 2017,95（11）:717⁃724.
|
| ［5］ |
Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria［J］. Allergy, 2018,73（7）:1393⁃1414. doi: 10.1111/all.13397.
|
| ［6］ |
Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update［J］. J Allergy Clin Immunol, 2014,133（5）:1270⁃1277. doi: 10.1016/j.jaci.2014.02.036.
|
| ［7］ |
中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 抗组胺药在皮肤科应用专家共识［J］. 中华皮肤科杂志, 2017,50（6）:393⁃396. doi: 10.3760/cma.j.issn.0412⁃4030. 2017.06.001.
|
| ［8］ |
Guillén⁃Aguinaga S, Jáuregui Presa I, Aguinaga⁃Ontoso E, et al. Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2016,175（6）:1153⁃1165. doi: 10.1111/bjd.14768.
|
| ［9］ |
中华医学会皮肤性病学分会荨麻疹研究中心. 抗IgE疗法——奥马珠单抗治疗慢性荨麻疹专家共识［J］. 中华皮肤科杂志, 2021,54（12）:1057⁃1062. doi: 10.35541/cjd.20210568.
|
| ［10］ |
温禾, 姚煦. 抗组胺药在特殊人群荨麻疹中的应用［J］. 皮肤科学通报, 2019,36（6）:647⁃652.
|
| ［11］ |
Zhao ZT, Ji CM, Yu WJ, et al. Omalizumab for the treatment of chronic spontaneous urticaria: a meta⁃analysis of randomized clinical trials［J］. J Allergy Clin Immunol, 2016,137（6）:1742⁃1750.e4. doi: 10.1016/j.jaci.2015.12.1342.
|
| ［12］ |
Namazy J, Cabana MD, Scheuerle AE, et al. The Xolair Pregnancy Registry （EXPECT）: the safety of omalizumab use during pregnancy［J］. J Allergy Clin Immunol, 2015,135（2）:407⁃412. doi: 10.1016/j.jaci.2014.08.025.
|
| ［13］ |
Kim S, Baek S, Shin B, et al. Influence of initial treatment modality on long⁃term control of chronic idiopathic urticaria［J］. PLoS One, 2013,8（7）:e69345. doi: 10.1371/journal.pone.0069345.
|
| ［14］ |
Son JH, Chung BY, Kim HO, et al. A histamine⁃free diet is helpful for treatment of adult patients with chronic spontaneous urticaria［J］. Ann Dermatol, 2018,30（2）:164⁃172. doi: 10.5021/ad.2018.30.2.164.
|
| ［15］ |
Kounis NG, Kounis GN, Soufras GD. Exercise⁃induced urticaria, cholinergic urticaria, and Kounis syndrome［J］. J Pharmacol Pharmacother, 2016,7（1）:48⁃50. doi: 10.4103/0976⁃500X.17 9355.
|
| ［16］ |
Bermingham WH, Ardern⁃Jones MR, Huissoon AP, et al. Forewarned is forearmed: chronic spontaneous urticaria as a potential risk to effective SARS⁃CoV⁃2 vaccine uptake and global public health［J］. Br J Dermatol, 2021,185（4）:838⁃839. doi: 10.1111/bjd.20495.
|
| ［17］ |
Bauer A, Dickel H, Jakob T, et al. Expert consensus on practical aspects in the treatment of chronic urticaria［J］. Allergo J Int, 2021,30（2）:64⁃75. doi: 10.1007/s40629⁃021⁃00162⁃w.
|
